Oropharyngeal shedding of herpesviruses before and after BNT162b2 mRNA vaccination against COVID-19

DISCUSSION: We did not find evidence for increased oropharyngeal reactivation of herpesviruses one week after BNT162b2.PMID:34481701 | DOI:10.1016/j.vaccine.2021.08.088
Source: Vaccine - Category: Allergy & Immunology Authors: Source Type: research